UBS Group’s IMS HEALTH HLDGS INC COM STK (DE) IMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,701
Closed -$53K 8557
2016
Q3
$53K Sell
1,701
-33,889
-95% -$990K ﹤0.01% 5480
2016
Q2
$903K Sell
35,590
-1,697
-5% -$43.5K ﹤0.01% 3469
2016
Q1
$990K Buy
37,287
+5,327
+17% +$132K ﹤0.01% 3262
2015
Q4
$815K Buy
31,960
+16,985
+113% +$475K ﹤0.01% 3568
2015
Q3
$436K Buy
14,975
+2,781
+23% +$85.4K ﹤0.01% 4020
2015
Q2
$374K Buy
12,194
+6,067
+99% +$176K ﹤0.01% 4360
2015
Q1
$166K Buy
6,127
+1,183
+24% +$30.7K ﹤0.01% 5022
2014
Q4
$127K Buy
+4,944
New +$125K ﹤0.01% 5468

UBS Group's IMS Position: Q4 2016 in Review

UBS Group sold out of IMS HEALTH HLDGS INC COM STK (DE) (IMS) in Q4 2016, closing a stake of 1,701 shares — an estimated $53K sold.

UBS Group first reported a position in IMS in Q4 2014 and held it in 8 quarters. The position peaked at $990K in Q1 2016. 0 funds tracked by Wall St. Rank hold IMS as of Q4 2016.

  • UBS Group reported no remaining IMS HEALTH HLDGS INC COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • UBS Group sold 1,701 IMS HEALTH HLDGS INC COM STK (DE) shares in Q4 2016, an estimated $53K.
  • UBS Group first reported a position in IMS HEALTH HLDGS INC COM STK (DE) in Q4 2014 and held it in 8 quarters.
  • UBS Group's IMS HEALTH HLDGS INC COM STK (DE) position peaked at $990K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held IMS HEALTH HLDGS INC COM STK (DE) as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.